Thrombotic risk factors in primary antiphospholipid syndrome: A 5-Year prospective study

Stroke

Volumn 36, Issue 7, 2005, Pages 1490-1494

  Turiel, Maurizio ^a   Sarzi Puttini, Piercarlo ^b   Peretti, Rossana ^a   Rossi, Edoardo ^b   Atzeni, Fabiola ^b   Parsons, Wendy ^c   Doria, Andrea ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antiphospholipid syndrome; Echocardiography; Thrombosis

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT;

ADULT; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CAUSE OF DEATH; CLINICAL EDUCATION; CLINICAL FEATURE; CONFIDENCE INTERVAL; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS;

ABORTION, SPONTANEOUS; ADULT; AGED; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREGNANCY; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; THROMBOCYTOPENIA; THROMBOSIS; TIME FACTORS;

EID: 22044440959     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000170645.40562.09     Document Type: Article

References (20)

1. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet. 1993;342:341-344.
2. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa MC, Hughes GR, Ingelmo M. Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46: 1019-1027.
3. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, Tolosa C, Franz J, Selva A, Ingelmo M. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med. 1994;96:3-9.
4. Asherson RA, Cervera R. Antiphospholipid antibodies and heart. Lessons and pitfalls for the cardiologist. Circulation. 1991;84:920-923.
5. Krnic-Barrie S, O'Connor CR, Looney SW, Pierangeli S, Harris EN. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Arch Intern Med. 1997;157:2101-2108.
6. The APASS investigators. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. J Am Med Assoc. 2004;291:576-584.
7. Finazzi G, Brancaccio V, Moia M, Ciaverella N, Mazzucconi MG, Schinco PC, Ruggeri M, Pogliani EM, Gamba G, Rossi E, Baudo F, Manotti C, D'Angelo A, Palareti G, De Stefano V, Berrettini M, Barbui T. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry. Am J Med. 1996;100:530-536.
8. Turiel M, Muzzupappa S, Gottardi B, Crema C, Sarzi-Puttini P, Rossi E. Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography. Lupus. 2000;9:406-412.
9. Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, Laskin C, Fortin P, Anderson D, Kearon C, Clarke A, Geerts W, Forgie M, Green D, Costantini L, Yacura W, Wilson S, Gent M, Kovacs MJ. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349:1133-1138.
10. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42:1309-1311.
11. Levine SR, Salowich-Palm L, Sawaya KL, Perry M, Spencer HJ, Winkler HJ, Alam Z, Carey JL. IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. Stroke. 1997;28:1660-1665.
12. Van Horn JT, Craven C, Ward K, Branch DW, Silver RM. Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta. 2004;25: 642-648.
13. Tincani A, Balestrieri G, Danieli E, Faden D, Lojacono A, Acaia B, Trespidi L, Ventura D, Meroni PL. Pregnancy complications of the antiphospholipid syndrome. Autoimmunity. 2003;36:27-32.
14. Zavaleta NE, Montes RM, Soto ME, Vanzzini NA, Amigo MC. Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study. J Rheumatol. 2004;31:2402-2407.
15. Erkan D, Yazici Y, Sobel R, Lockshin MD. Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol. 2000;27: 2817-2821.
16. Vaarala O, Manttari M, Manninen V, Tenkanen L, Puurunen M, Aho K, Palosuo T. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation. 1995;91:23-27.
17. Munoz-Rodriguez FJ, Font J, Cervera R, Reverter JC, Tassies D, Espinosa G, Lopez-Soto A, Carmona F, Balasch J, Ordinas A, Ingelmo M. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum. 1999;29:182-190.
18. Glueck CJ, Lang JE, Tracy T, Sieve-Smith L, Wang P. Evidence that anticardiolipin antibodies are independent risk factor for atherosclerotic vascular disease. Am J Cardiol. 1999;83:1490-1494.
19. Janardhan V, Wolf PA, Kase CS, Massaro JM, D'Agostino RB, Franzblau C, Wilson PWF. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham Cohort and Offspring Study. Stroke. 2004;35:736-741.
20. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332:993-997.